FINANCIALS

RLAY Relay Therapeutics Inc 1812364

Income Statement
Revenue	rlay-20241231	10,007,000
Net Income	rlay-20241231	-337,708,000
Profit Margin		-3374.72%

Balance Sheet
Current Assets	809,204,000
Assets	871,296,000
Current Liabilities	50,729,000
Liabilities	93,504,000
Equity	777,792,000
Shares Out	162,461,000

Cash Flow Statement
Operating Cash Flow	-249,107,000
Investing Cash Flow	-41,083,000

Market Analysis
Market Cap	1,283,837,631
Price	3.32
BVPS	4.79
PB	0.68
EPS	-2.52
PS	32.07
FCF	-290,190,000

Dividends

Earnings

Find a discrepancy? The most accurate way to find company fundamental data is to view RLAY documents filed with the SEC.

RLAY Filings Clear

View A List of Tickers